OptimizeRx to Participate at Investor Conferences in November
20 Ottobre 2020 - 1:31PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies, physicians and
patients, has been invited to participate in two investor
conferences being held in November.
Event: ROTH Technology Virtual ConferenceAttendance Date:
November 11, 2020Format: Virtual 1x1 and small group
meetingsRegistration: Email registration@roth.com or click
here.
Event: Stifel Midwest One-on-One Growth ConferenceAttendance
Date: November 12, 2020Format: Virtual 1x1 meetingsRegistration:
Please contact your Stifel institutional sales representative.
OptimizeRx management is scheduled to participate in
virtual one-on-one meetings with institutional investors and
analysts at both conferences.
Management will discuss the company’s recently reported
preliminary results for the third quarter of 2020. The company
expects record revenue of more than $10.0 million, up over 100%
versus the same year-ago quarter, along with positive non-GAAP net
income.
They will review how this growth is being driven organically by
a combination of enterprise deals and tactical programs, as its
life science customers increasingly see the value in transparent
access to physicians and patients via the OptimizeRx digital health
platform.
To schedule a virtual one-on-one meeting with OptimizeRx,
you may submit your request via the links provided upon your
registration for the conferences. For any questions about the
company, please contact Ron Both of CMA at (949) 432-7557
or submit your request here.
About Roth Capital
Partners ROTH
Capital Partners, LLC (ROTH), is a relationship-driven investment
bank focused on serving emerging growth companies and their
investors. As a full-service investment bank, ROTH provides capital
raising, M&A advisory, analytical research, trading,
market-making services and corporate access. Headquartered in
Newport Beach, CA, ROTH is privately-held and employee owned, and
maintains offices throughout the U.S. For more information on ROTH,
please visit www.roth.com.
About StifelStifel is a full-service investment
firm with a distinguished history of providing securities
brokerage, investment banking, trading, investment advisory, and
related financial services to individual investors, institutions,
corporations, and municipalities. Established in 1890 and
headquartered in St. Louis, Missouri, Stifel is one of the nation’s
leading firms.
For more information about Stifel, visit www.stifel.com.
About OptimizeRxOptimizeRx is a digital health
company that provides communications solutions for life science
companies, physicians and patients. Connecting over half of
healthcare providers in the U.S. and millions of patients through a
proprietary network, the OptimizeRx digital health platform helps
patients afford and stay on medications. The platform unlocks new
patient and physician touchpoints for life science companies along
the patient journey, from point-of-care, to retail pharmacy,
through mobile patient engagement.
For more information, follow the company
on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
Statements This
press release contains forward-looking statements within the
definition of Section 27A of the Securities Act of 1933, as
amended, and such as in section 21E of the Securities Act of 1934,
as amended. These forward-looking statements should not be used to
make an investment decision. The words 'estimate,' 'possible' and
'seeking' and similar expressions identify forward-looking
statements, which speak only as to the date the statement was made.
The company undertakes no obligation to publicly update or revise
any forward-looking statements, whether because of new information,
future events, or otherwise. Forward-looking statements are
inherently subject to risks and uncertainties, some of which cannot
be predicted, or quantified. Future events and actual results could
differ materially from those set forth in, contemplated by, or
underlying the forward-looking statements. The risks and
uncertainties to which forward-looking statements are subject
include, but are not limited to, the effect of government
regulation, competition and other material risks.
OptimizeRx Contact Doug Baker, CFOTel
(248) 651-6568 (x807)dbaker@optimizerx.com
Media Relations Contact Maira Alejandra,
Media Relations ManagerTel (754)
245-7070 malejandra@optimizerx.com
Investor Relations Contact Ron Both,
CMA Tel (949) 432-7557 oprx@cma.team
Grafico Azioni OptimizeRx (NASDAQ:OPRX)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni OptimizeRx (NASDAQ:OPRX)
Storico
Da Lug 2023 a Lug 2024